Health Care: Drugs

Eli Lilly and Company (LLY: NYSE)

$59.685 0.265 | 0.45%
04/16/14 - 11:11 AM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 23.11B 22.60B 24.29B 23.08B
Cost of Sales 3.46B 3.33B 3.69B 3.04B
Gross Operating Profit 19.65B 19.27B 20.59B 20.04B
Selling, General, and Administrative Expenses 7.13B 7.51B 7.88B 7.05B
Research & Development 5.53B 5.28B 5.02B 4.88B
Operating Income before D & A (EBITDA) 6.99B 6.48B 7.69B 8.10B
Depreciation & Amortization 1.45B 1.46B 1.37B 1.33B
Interest Income 119.70M 105.00M 79.90M 51.90M
Other Income - Net 559.30M 0.00 -72.90M 128.60M
Special Income / Charges -234.80M 465.70M -1.18B -292.00M
Total Income Before Interest Expenses (EBIT) 6.05B 5.59B 5.54B 6.71B
Interest Expense 160.10M 177.80M 186.00M 185.50M
Pre-Tax Income 5.89B 5.41B 5.35B 6.53B
Income Taxes 1.20B 1.32B 1.00B 1.46B
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 4.68B 4.09B 4.35B 5.07B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 4.68B 4.09B 4.35B 5.07B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 4.68B 4.09B 4.35B 5.07B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
4.86B 3.62B 5.14B 5.31B
Preferred Dividends
Net Income Available To Common 4.68B 4.09B 4.35B 5.07B
Basic EPS from Continuing Ops. 4.33 3.67 3.93 4.58
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 4.33 3.67 3.93 4.58
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 -0.03 0.00
Basic EPS, Total 4.33 3.67 3.90 4.58
Basic Normalized Net Income/Share 4.50 3.25 4.64 4.80
EPS fr Continuing Ops. 4.32 3.66 3.90 4.58
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 4.32 3.66 3.90 4.58
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 4.32 3.66 3.90 4.58
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
4.48 3.24 4.61 4.80
Dividends Paid per Share 1.96 1.96 1.96 1.96

Portfolios with LLY

Latest LLY Headlines from TheStreet

More Financial News for LLY

Press Releases for LLY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter